For research use only. Not for therapeutic Use.
Foravirumab（Cat No.:I042098）is an investigational monoclonal antibody being developed for the treatment of viral infections, particularly respiratory syncytial virus (RSV). It works by targeting the F protein of the RSV, preventing the virus from entering human cells and reducing viral replication. Foravirumab is being studied as a potential therapeutic option for both treating active RSV infections and providing prophylactic protection in high-risk populations, such as infants, elderly individuals, and immunocompromised patients. Clinical trials are ongoing to evaluate its safety, efficacy, and potential role in managing RSV infections.
| CAS Number | 944548-38-3 |
| Purity | ≥95% |
